Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Cell and Molecular Pharmacology and Experimental Therapeutics,
Hollings Cancer Center
Russell Spencer-Smith has not added Biography.
If you are Russell Spencer-Smith and would like to personalize this page please email our Author Liaison for assistance.
Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene Apr, 2019 | Pubmed ID: 30573767
Correction: Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene May, 2019 | Pubmed ID: 30710144
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Cell reports Feb, 2022 | Pubmed ID: 35139380
Medical University of South Carolina
National Cancer Institute-Frederick
Russell Spencer-Smith1,2,3
1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina,
2Hollings Cancer Center, Medical University of South Carolina,
3Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved